Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03341052 · ClinicalTrials.gov registry record · NA

Characterization of Bile Acid Pathway in Obesity

A NA study of Obesity, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03341052 is a NA study of Obesity that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03341052, a NA study of Obesity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

It is unknown whether the bile acid pathway is altered in obesity. This study is designed to compare obesity and health to determine if the bile acid pathway differs depending on health state.

Conditions Studied

Interventions

  • OTHER Normal Diet
  • OTHER High Fat Diet
  • OTHER Low Fat Diet

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-11-14
Est. Completion 2021-10-09
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03341052

The ClinicalTrials.gov registry entry for NCT03341052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Normal Diet is the first listed.

NCT03341052 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03341052 about?

NCT03341052 is a clinical study titled "Characterization of Bile Acid Pathway in Obesity". It is unknown whether the bile acid pathway is altered in obesity. This study is designed to compare obesity and health to determine if the bile acid pathway differs depending on health state.

What is the current status of trial NCT03341052?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-11-14. Estimated completion is 2021-10-09.

What conditions does trial NCT03341052 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03341052?

The interventions under investigation include: Normal Diet (OTHER), High Fat Diet (OTHER), Low Fat Diet (OTHER).

Who is sponsoring clinical trial NCT03341052?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03341052 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.